Article
Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.
Clinical genetics - 1 Oct 2016
Wallace S, Guo D-C, Regalado E, Mellor-Crummey L, Bamshad M, Nickerson D A, Dauser R, Hanchard N, Marom R, Martin E, Berka V, Sharina I, Ganesan V, Saunders D, Morris S A, Milewicz D M
Abstract excerpt
Moyamoya disease (MMD) is a progressive vasculopathy characterized by occlusion of the terminal portion of the internal carotid arteries and its branches, and the formation of compensatory moyamoya collateral vessels. Homozygous mutations in GUCY1A3 have been reported as a cause of MMD and achalasia. Probands (n = 96) from unrelated families underwent sequencing of GUCY1A3. Functional studies were performed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.